European Companies Search Engine
MD: S. H. · No longer MD (2) · Change of headquarters: Spreewälder Arzneimittel GmbH, m2m new business GmbH · Capital: €50,000 · Shareholder agreement · Seat: Gröditsch · Proxy policy … Hrb 28 Mar 2006 German Trade Register Announcements, Germany (24/03/2006)
Overview
Text
Spreewälder Arzneimittel GmbH, Gröditsch (
Unnamed street ??, 15910 Gröditsch, Germany
). Company: Spreewälder Arzneimittel GmbH. Seat: Gröditsch. Purpose: manufacture of medicinal products and related products and distribution of them in retail and wholesale, import and export, generally all transactions and works which relate, directly or indirectly, in whole or in part to the purpose of the company. Share capital: EUR 50,000.00. General; Representation regulation: If a managing director is appointed, he shall represent the company alone. If several directors have been appointed, the company is represented jointly by two directors or by a managing director with an authorized representative. Was Managing Director: ????, ??????, *??.??.????, Mainz; with the power to represent the company alone; with the power to enter into legal transactions with itself or as a representative of third parties. Was Managing Director: ????????, ?????? Johanna Friederike, *??.??.????, Berlin; with the power to represent the company alone; with the power to enter into legal transactions with itself or as a representative of third parties. Managing Director: Hauptmann, Stefan, *??.??.????, Berlin; with the power to represent the company alone; with the power to enter into legal transactions with itself or as a representative of third parties. GmbH. Partnership agreement of July 31, 2001 with amendment of the amendment of January 23, 2003 (e.g. transfer of registered office from Hamburg Amtsgericht Hamburg HRB 83223) to Berlin and amendment of December 13, 2005. By resolution of the shareholders' meeting of December 13, 2005 the registered office of the company has been moved from Berlin (Amtsgericht Charlottenburg (Berlin) HRB 89149 B) to Gröditsch, company and subject matter has been changed, the share capital is increased from EUR 25,000.00 to EUR 50,000.00 and the partnership agreement is completely redrafted, in particular in Section 1 (company and registered office), Section 2 (object of the company), Section 5 (share capital). As not registered is published: Announcements of the company are made in the electronic Federal Gazette.
This filing was translated from German to English. The filing refers to a past date, and does not necessarily reflect the current state. The latest known state is available on the following page: Spreewälder Arzneimittel GmbH, Märkische Heide, Germany.